Metagenomi Appoints Laurence Reid, PhD to its Board of Directors - KalVista Pharmaceuticals (NASDAQ:KALV), Metagenomi (NASDAQ:MGX)
Summary by Benzinga
1 Articles
1 Articles
Metagenomi Appoints Laurence Reid, PhD to its Board of Directors - KalVista Pharmaceuticals (NASDAQ:KALV), Metagenomi (NASDAQ:MGX)
EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (NASDAQ:MGX) (the "Company"), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing toolbox, today announced the appointment of Laurence Reid, PhD, to its Board of Directors. "We are delighted to welcome Dr. Reid to our Board of Directors. Laurence brings a remarkable track record as a company build…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium